Curcumin prevents obesity, diabetes and fatty liver
By Jimmy Downs
Saturday April 27, 2013 (foodconsumer.org) -- curcumin an ingredient found in turmeric has been used to prevent many chronic diseases including obesity, type 2 diabetes and liver disease. Recent studies show that this dietary supplement possesses potent antioxidant, anticarcinogenic, antiinflammatory and hypoglycemic properties.
A new study in Journal of Physiology and Biochemistry has now found that curcumin supplementation reduces serum fetuin-A, which is involved in metabolic disorders such as visceral obesity, insulin resistance, diabetes and fatty liver, according to clinical studies.
For the study, Yildiz Öner-?yido?an and colleagues examined the effect of curcumin treatment on serum fetuin-A concentrations and hepatic lipids and antioxidant status in rats fed a high fat diet.
Rats fed 100 and 400 mg/kg body weight per day had reduced levels of liver triglycerides and serum fetuin A levels, the researchers found.
It is believed that 10 grams of curcumin per day is safe for humans to use. In a prior study, Indian researchers tested 6 grams of curcumin per day in people with pre-diabetes and found the dietary supplement very effective in preventing type 2 diabetes in the subjects.
(Send your news to firstname.lastname@example.org, Foodconsumer.org is part of the Infoplus.com ™ news and information network)
- Elevated cholesterol and triglycerides may increase the risk for prostate cancer recurrence
- New Film “Second Opinion” Exposes the Truth About a 40-Year Long Cover-Up of Laetrile Cancer Treatment
- New “Conscious Capital” Fund, MetaBrand Capital, Invests $5.75 Million in Organic, "Healthy Energy" Beverage Maker Runa
- Resveratrol supplements may prevent osteoporosis
- Amygdalin Blocks Bladder Cancer Cell Growth In Vitro by Diminishing Cyclin A and cdk2